{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:29:48Z","timestamp":1791329388564,"version":"4.3.1"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T00:00:00Z","timestamp":1362009600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0058014","type":"journal-article","created":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T08:44:59Z","timestamp":1362127499000},"page":"e58014","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":202,"title":["Increased Circulating miR-21 Levels Are Associated with Kidney Fibrosis"],"prefix":"10.1371","volume":"8","author":[{"given":"Fran\u00e7ois","family":"Glowacki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Savary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Gnemmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Buob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Van der Hauwaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Lo-Guidice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Bouy\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Hazzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Pottier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl","family":"Perrais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Cauffiez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,2,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00041552-200405000-00003","article-title":"Mechanisms of tubulointerstitial fibrosis","volume":"13","author":"M Iwano","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2010.120","article-title":"Renal fibrosis: novel insights into mechanisms and therapeutic targets","volume":"6","author":"P Boor","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jama.2010.356","article-title":"Association of caveolin-1 gene polymorphism with kidney transplant fibrosis and allograft failure","volume":"303","author":"J Moore","year":"2010","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1038\/ki.2010.419","article-title":"The pathology of chronic allograft dysfunction","volume":"119","author":"LC Racusen","year":"2010","journal-title":"Kidney Int"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ki.2010.88","article-title":"An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease","volume":"77","author":"O Garc\u00eda-S\u00e1nchez","year":"2010","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.7150\/ijbs.7.1056","article-title":"Diverse roles of TGF-\u03b2\/Smads in renal fibrosis and inflammation","volume":"7","author":"HY Lan","year":"2011","journal-title":"Int J Biol Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3748\/wjg.v13.i22.3056","article-title":"Transforming growth factor-beta and fibrosis","volume":"13","author":"F Verrecchia","year":"2007","journal-title":"World J Gastroenterol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5000054","article-title":"Renal fibrosis: new insights into the pathogenesis and therapeutics","volume":"69","author":"Y Liu","year":"2006","journal-title":"Kidney Int"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1681\/ASN.2010080793","article-title":"Mechanisms of tubulointerstitial fibrosis","volume":"21","author":"M Zeisberg","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.gde.2005.08.005","article-title":"How microRNAs control cell division, differentiation and death","volume":"15","author":"EA Miska","year":"2005","journal-title":"Curr Opin Genet Dev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1065062","article-title":"An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans","volume":"294","author":"NC Lau","year":"2001","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1064921","article-title":"Identification of novel genes coding for small expressed RNAs","volume":"294","author":"M Lagos-Quintana","year":"2001","journal-title":"Science"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"M Esteller","year":"2011","journal-title":"Nat Rev Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4110\/in.2011.11.6.309","article-title":"MicroRNAs in Human Diseases: From Lung, Liver and Kidney Diseases to Infectious Disease, Sickle Cell Disease and Endometrium Disease","volume":"11","author":"TY Ha","year":"2011","journal-title":"Immune Netw"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1111\/j.1742-4658.2010.07632.x","article-title":"MicroRNAs and the regulation of fibrosis","volume":"277","author":"X Jiang","year":"2010","journal-title":"FEBS J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.trsl.2011.01.011","article-title":"MicroRNAs in kidney function and disease","volume":"157","author":"S Akkina","year":"2011","journal-title":"Transl Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2217\/14796694.3.5.521","article-title":"miRNAs and their potential for use against cancer and other diseases","volume":"3","author":"E Tili","year":"2007","journal-title":"Future Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr168","article-title":"Toxicological implications of modulation of gene expression by microRNAs","volume":"123","author":"T Yokoi","year":"2011","journal-title":"Toxicol Sci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/14712590902932889","article-title":"MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases","volume":"9","author":"MA Cortez","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrclinonc.2011.76","article-title":"MicroRNAs in body fluids \u2013 the mix of hormones and biomarkers","volume":"8","author":"MA Cortez","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mrfmmm.2011.03.004","article-title":"Extracellular microRNA: a new source of biomarkers","volume":"717","author":"A Etheridge","year":"2011","journal-title":"Mutat Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ki.2009.86","article-title":"Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy","volume":"75","author":"RL Chevalier","year":"2009","journal-title":"Kidney Int"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1365-2362.2011.02535.x","article-title":"Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis","volume":"41","author":"X Fu","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4161\/cbt.10.12.14252","article-title":"MicroRNA-21: a novel therapeutic target in human cancer","volume":"10","author":"X Pan","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e3148","DOI":"10.1371\/journal.pone.0003148","article-title":"Serum microRNAs are promising novel biomarkers","volume":"3","author":"S Gilad","year":"2008","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"X Chen","year":"2008","journal-title":"Cell Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1152\/ajprenal.00273.2011","article-title":"Identification of a microRNA signature in renal fibrosis: role of miR-21","volume":"301","author":"A Zarjou","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref28","first-page":"121ra18","article-title":"MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways","volume":"4","author":"BN Chau","year":"2012","journal-title":"Sci Transl Med"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Duffield J, Grafals M, Portilla D. MicroRNAs are potential therapeutic targets in fibrosing kidney disease: lessons from animal models. Drug Disovery Today Disease Models. In press.","DOI":"10.1016\/j.ddmod.2012.08.004"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1681\/ASN.2010121308","article-title":"TGF-\u03b2\/Smad3 signaling promotes renal fibrosis by inhibiting miR-29","volume":"22","author":"W Qin","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"C Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","article-title":"Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis","volume":"105","author":"E van Rooij","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1042\/BST20120085","article-title":"Pleiotropy of microRNA-192 in the kidney","volume":"40","author":"RH Jenkins","year":"2012","journal-title":"Biochem Soc Trans"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1681\/ASN.2010020134","article-title":"miR-192 mediates TGF-beta\/Smad3-driven renal fibrosis","volume":"21","author":"AC Chung","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1042\/BST0370918","article-title":"miR-21 as a key regulator of oncogenic processes","volume":"37","author":"SD Selcuklu","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1582-4934.2008.00556.x","article-title":"miR-21: a small multi-faceted RNA","volume":"13","author":"AM Krichevsky","year":"2009","journal-title":"J Cell Mol Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1582-4934.2008.00510.x","article-title":"MicroRNA and cancer \u2013 focus on apoptosis","volume":"13","author":"Y Wang","year":"2009","journal-title":"J Cell Mol Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.20100035","article-title":"miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis","volume":"207","author":"G Liu","year":"2010","journal-title":"J Exp Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.trsl.2011.01.012","article-title":"MicroRNAs in idiopathic pulmonary fibrosis","volume":"157","author":"KV Pandit","year":"2011","journal-title":"Transl Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1681\/ASN.2010111168","article-title":"Smad3-mediated upregulation of miR-21 promotes renal fibrosis","volume":"22","author":"X Zhong","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/HCO.0b013e328345983d","article-title":"MicroRNAs in the cardiovascular system","volume":"26","author":"M Han","year":"2011","journal-title":"Curr Opin Cardiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1172\/JCI45938","article-title":"Comparison of different miR-21 inhibitor chemistries in a cardiac disease model","volume":"121","author":"T Thum","year":"2011","journal-title":"J Clin Invest"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Villar AV, Garc\u00eda R, Merino D, Llano M, Cobo M, <etal>et al<\/etal>.. (2012) Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients. Int J Cardiol. Aug 8. (Epub ahead of print).","DOI":"10.1016\/j.ijcard.2012.07.021"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"M Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/FTD.0b013e3181e44244","article-title":"The pharmacogenetics of calcineurin inhibitor-related nephrotoxicity","volume":"32","author":"DA Hesselink","year":"2010","journal-title":"Ther Drug Monit"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions","volume":"8","author":"K Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"K Livak","year":"2001","journal-title":"Methods"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0058014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T05:17:13Z","timestamp":1589001433000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0058014"}},"subtitle":[],"editor":[{"given":"Jeremy Stuart","family":"Duffield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,28]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0058014","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,28]]}}}